UnitedHealth (UNH) Appoints Patrick Conway to Lead Optum Health Amid Strategic Shake-Up

UnitedHealth Group Incorporated (NYSE:UNH) is one of the 13 best blue-chip stocks to buy, according to analysts. On June 26, UNH appointed Patrick Conway to lead its Optum Health division, citing his expertise in value-based care. Conway, who previously headed Optum Rx and became CEO of the broader Optum segment in April, replaces Amar Desai, now vice-chairman. The leadership reshuffle follows UnitedHealth’s first earnings miss since 2008 and reflects its strategy to strengthen executive depth across business units.

A healthcare professional in a meeting with a patient discussing care options using digital technology.

Optum Health, UnitedHealth’s care delivery arm, has faced recent challenges, including reduced Medicare Advantage engagement and a Department of Justice probe into its billing practices. New CEO Stephen Hemsley acknowledged the underperformance during a June shareholder meeting and confirmed a company-wide review is underway to address operational concerns.

UnitedHealth Group Incorporated (NYSE:UNH) offers healthcare coverage alongside data analytics and software solutions. Its operations span four core segments: OptumRx, OptumInsight, OptumHealth, and UnitedHealthcare—each playing a key role in the company’s strong, integrated healthcare ecosystem.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Most Undervalued Gold Stocks to Buy According To Analysts and 10 Undervalued Tech Stocks Flying Under Wall Street’s Radar.

Disclosure: None.